Flavaglines: A group of efficient growth inhibitors block cell cycle progression and induce apoptosis in colorectal cancer cells

International Journal of Cancer

Volumn 109, Issue 6, 2004, Pages 933-940

  Hausott, Barbara ^a   Greger, Harald ^b   Marian, Brigitte ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; Bioactive plant compound; Cell cycle block; Colon cancer; Flavagline; Rocaglamide derivative

Indexed keywords

4' DESMETHYL 3',4' METHYLENEDIOXYROCAGLAOL; AGLAFOLINE; AGLAIASTATIN; AGLAROXIN A; FLAVAGLINE DERIVATIVE; FLAVONOL DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROCASPASE 3; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL XL; ROCAGLAMIDE; ROCAGLAOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; COLORECTAL CARCINOMA; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOMA; ANIMALS; APOPTOSIS; BCL-X PROTEIN; BENZOFURANS; CELL CYCLE; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; GROWTH INHIBITORS; HUMANS; INTESTINES; MATRIX METALLOPROTEINASES; MELIACEAE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS;

EID: 16244410898     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20033     Document Type: Article

References (32)

1. Ragnhammar P, Hafstrom L, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol 2001;40:282-308.
2. Macdonald JS. Adjuvant therapy of colon cancer. CA Cancer J Clin 1999;49:202-19.
3. Macdonald JS, Astrow AB. Adjuvant therapy of colon cancer. Semin Oncol 2001;28:30-40.
4. Pezzuto JM. Plant-derived anticancer agents. Biochem Pharmacol 1997;53:121-33.
5. Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development. J Nat Prod 1997;60:52-60.
6. Baker JT, Borris RP, Carte B, Cordell GA, Soejarto DD, Cragg GM, Gupta MP, Iwu MM, Madulid DR, Tyler VE. Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod 1995;58:1325-57.
7. Greger H, Pache T, Brem B, Bacher M, Hofer O. Insecticidal flavaglines and other compounds from Fijian Aglaia species. Phytochemistry 2001;57:57-64.
8. Bacher M, Hofer O, Brader G, Vajrodaya S, Greger H. Thapsakins: possible biogenetic intermediates towards insecticidal cyclopenta(b)benzofurans from Aglaia edulis. Phytochemistry 1999;52:253-63.
9. Brader G, Vajrodaya S, Greger H, Bacher M, Kalchhauser H, Hofer O. Bisamides, lignans, triterpenes, and insecticidal cyclopenta[b]benzofurans from Aglaia species. J Nat Prod 1998;61:1482-90.
10. King ML, Chiang CC, Ling HC, Fujita E, Ochiai M, McPhail AT. X-ray structure of rocaglamide, a novel antileukemic 1H-cyclopenta(b)benzofuran from Aglaia elliptifolia. J Chem Soc Chem Commun 1982;20:1150-1.
11. Dumontet V, Thoison O, Omobuwajo OR, Martin MT, Perromat G, Chiaroni A, Riche C, Pais M, Sevenet T. New nitrogenous and aromatic derivatives from Aglaia argentea and A. forbesii. Tetrahydron 1996;52:6931-42.
12. Cui B, Chai H, Santisuk T, Reutrakul V, Farnsworth NR, Cordell GA, Pezzuto JM, Kinghorn AD. Novel cytotoxic IH-cyclopenta(b)benzofuran lignans from Aglaia elliptica. Tetrahydron 1997;53:17625-32.
13. Wu TS, Liou MJ, Kuoh CS, Teng CM, Nagao T, Lee KH. Cytotoxic and antiplatelet aggregation principles from Aglaia elliptifolia. J Nat Prod 1997;60:606-8.
14. Lee SK, Cui B, Mehta RR, Kinghom AD, Pezzuto JM. Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica. Chem Biol Interact 1998;115:215-28.
15. Wang SK, Cheng YJ, Duh CY. Cytotoxic constituents from leaves of Aglaia elliptifolia. J Nat Prod 2001;64:92-4.
16. Wang SK, Duh CY. Cytotoxic cyclopenta[b]benzofuran derivatives from the stem bark of Aglaia formosana. Planta Med 2001;67:555-7.
17. Proksch P, Edrada RA, Ebel R, Bohnenstengel F, Nugroho BW. Chemistry and biological activity of rocaglamide derivatives and related compounds in Aglaia species (Meliaceae). Curr Org Chem 2001;5:923-38.
18. Ohse T, Ohba S, Yamamoto T, Koyano T, Umezawa K. Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata. J Nat Prod 1996;59:650-2.
19. Bohnenstengel FI, Steube KG, Meyer C, Nugroho BW, Hung PD, Kiet LC, Proksch P. Structure-activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae). Z Naturforsch [C] 1999;54:55-60.
20. Hafez MM, Infante D, Winawer S, Friedman E. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Cell Growth Differ 1990;1:617-26.
21. Willson JK, Bittner GN, Oberley TD, Meisner LF, Weese JL. Cell culture of human colon adenomas and carcinomas. Cancer Res 1987;47:2704-13.
22. Richter M, Jurek D, Wrba F, Kaserer K, Wurzer G, Kaner-Hanusch J, Marian B. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur J Cancer 2002;38:1937-45.
23. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′ -tetrachloro-1,1′,3,3′- tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40-5.
24. Baumann B, Bohnenstengel F, Siegmund D, Wajant H, Weber C, Herr I, Debatin KM, Proksch P, Wirth T. Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells. J Biol Chem 2002;277:44791-800.
25. Bohnenstengel FI, Steube KG, Meyer C, Quentmeier H, Nugroho BW, Proksch P, 1H-Cyclopenta[b]benzofuran lignans from Aglaia species inhibit cell proliferation and alter cell cycle distribution in human monocytic leukemia cell lines. Z Naturforsch [C] 1999;54:1075-83.
26. Partik G, Hochegger K, Schorkhuber M, Marian B. Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro. J Cancer Res Clin Oncol 1999;125:379-88.
27. Robinson MJ, Cobb MH. Mitogen-activated protein kinese pathways. Curr Opin Cell Biol 1997;9:180-6.
28. Heidenreich KA, Kummer JL. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J Biol Chem 1996;271:9891-4.
29. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995;270:1326-31.
30. Pandey P, Raingeaud J, Kaneki M, Weichselbaum R, Davis RJ, Kufe D, Kharbanda S. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms. J Biol Chem 1996;271:23775-9.
31. Kharbanda S, Bharti A, Pei D, Wang J, Pandey P, Ren R, Weichselbaum R, Walsh CT, Kufe D. The stress response to ionizing radiation involves c-Abl-dependent phosphorylation of SHPTP1. Proc Natl Acad Sci USA 1996;93:6898-901.
32. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 1998;273:4027-34.